Epigenetic post-transcriptional modifications of histone tails are thought to help in coordinating gene expression during development. An epigenetic signature is set in pluripotent cells and interpreted later at the onset of differentiation. In pluripotent cells, epigenetic marks normally associated with active genes (H3K4me3) and with silent genes (H3K27me3) atypically co-occupy chromatin regions surrounding the promoters of important developmental genes. However, it is unclear how these epigenetic marks are recognized when cell differentiation starts and what precise role they play. Here, we report the essential role of the nuclear receptor peroxisome proliferator-activated receptor b (PPARb, NR1C2) in Xenopus laevis early development. By combining loss-of-function approaches, large throughput transcript expression analysis by the mean of RNA-seq and intensive chromatin immunoprecipitation experiments, we unveil an important cooperation between epigenetic marks and PPARb. During Xenopus laevis gastrulation PPARb recognizes H3K27me3 marks that have been deposited earlier at the pluripotent stage to activate early differentiation genes. Thus, PPARbis the first identified transcription factor that interprets an epigenetic signature of pluripotency, in vivo, during embryonic development. This work paves the way for a better mechanistic understanding of how the activation of hundreds of genes is coordinated during early development.
Introduction
How a single egg cell divides and invariably produces all sorts of differentiated cells that form the adult organism is the foundational question of developmental biology. Because all the cells of the organism share the same genome inherited from the zygote, different epigenetic landscapes are the main distinctive genomic feature of differentiated cells. This points to the important role of heritable epigenetic marks such as DNA methylation, histone H3 tri-methylation on lysine 4 (H3K4me3) or on lysine 27 (H3K27me3) in the process of differentiation [1, 2] . Epigenetic marks not only contribute to the progression of cell differentiation, they also help in coordinating the switch from pluripotency to early differentiation. Indeed, an epigenetic signature is set in pluripotent cells before the onset of differentiation. In cultured embryonic stem cells (ESCs) and pluripotent stem cells, and the developing fish embryo, 'bivalent' genes bear opposing epigenetic marks in the vicinity of their promoter region: the activating H3K4me3 and the repressive H3K27me3 [3, 4] . These bivalent genes mostly encode important developmental regulators [3, 5, 6, 7, 8] , and many are synchronously induced during cell differentiation, concomitantly losing their repressive H3K27me3 mark [5, 6, 7, 9] . This process is thus thought to facilitate a coordinated wave of gene expression by identifying the few hundred genes that are important for the very early differentiation in the total repertoire of more than 20,000.
However, the relation between gene expression at the onset of differentiation and bivalency is complex: many bivalent genes are synchronously activated [3, 5] while some others become repressed [10] . Therefore, it is likely that other factors should be taken into consideration, and in particular the transcription factors that should interpret this epigenetic signature at the time of differentiation. However, if common signal transducers are likely implicated in H3K27me3 loss at bivalent genes during differentiation in ESC, how specific genes are recognized is unclear and in vivo knowledge is limited [11, 12, 13] .
Here we report that the nuclear hormone receptor peroxisome proliferator-activated receptor b (PPARb, NR1C2) can interpret an epigenetic signature of pluripotency during Xenopus laevis gastrulation.
PPARb is a ligand-activated transcription factor important for cell differentiation in the adult [14] and in the placenta [15] , but its role in the embryo has not been studied properly. We show that in Xenopus laevis, PPARb is essential for neural and muscle differentiation as early as in gastrulation when a massive change in transcript level occurs. By using genomic (RNA-seq) and bioinformatics approaches we propose that PPARb preferentially activates bivalent genes at gastrulation. This hypothesis is supported by direct examination of developing Xenopus laevis embryos using chromatin immunoprecipitation (ChIP). Most importantly, pharmacologic manipulation of H3K27me3 levels in the embryo indicates that it is this mark that triggers gene activation by PPARb. Our work represents an important step towards a better understanding of the role of epigenetic marks in the switch from pluripotent to differentiated state.
Materials and Methods

Animal care and housing
Animal care and handling procedures were approved by the Commission de Surveillance de l'Expérimentation Animale of the Canton de Vaud, Switzerland.
In vitro fertilization, embryo microinjections, and drug treatments X. laevis oocyte collection, fertilization, and de-jellying were performed according to standard procedures [16] . Unless otherwise indicated, injections were done at the 2-cell stage, with a single injection in each of the two cells. 3-deazaneplanocin A (DZNep) (Cayman) treatment: X. laevis embryos were injected with Co or PPARb MO (morpholino) and allowed to develop until stage 5 when DZNep or DMSO was added to the water. Embryos were collected at stage 10.5 for RT-qPCR or ChIP with H3K27me3 antibody.
RNA-seq
The paired-end tags with no more than 5 N in each pair were mapped onto 10,691 distinct RefSeq X. laevis mRNA with fetchGWI, which is part of the Tagger software suite [17] , using up to one mismatch per tag. Paired-end tags matching a unique mRNA with a separation of 500 nt at most were retained as valid hits (3.4 and 4.1 million for Co and MO, respectively). The number of tags matching each mRNA was counted and taken as a measure of the transcript abundance to compute relative abundance of MO. We assumed that most of the genes would be unaffected by the MO and multiplied the MO counts by 0.799 to obtain similar distribution counts between Co and MO. The values for the adjusted lowest, 1 st quartile, median, 3 rd quartile, and maximum number of tags were 1, 26, 99, 304, and 69,440 for the control and 0.8, 26, 99, 305, and 67,990 for MO, respectively.
Additional technical information about functional analysis of the RNA-seq is given in Protocol S1.
Antibodies
An affinity-purified polyclonal antibody against xenopus PPARb was produced by immunizing rabbits with the peptide KLH-VQAPVSDSAAPDSPV (Eurogentec). This antibody detected a 45-kDa protein after immunoblotting of whole-embryo extracts (Fig. S1B) . Moreover, a band migrating at the same position was detected when PPAR proteins were pooled-down using a DNA_biotinylated probe containing three copies in tandem of the peroxisome proliferator-activated receptor response element (3xPPRE motif). This band corresponded to PPARb because PPARa and PPARc have an expected mass of about 50 kDa and because the efficiency of the pull-down increased when GW501516, a selective PPARb agonist, was added (Fig.  S1B) .
We used anti-H3K4me3 from Abcam (ab8580), antiH3K27me3 from Millipore (07-449), and anti-b-actin from Sigma (AC-40).
Immunoblotting/DNAP/ChIP
Protein extraction for immunoblotting was done according to the De Robertis online protocol for phospho-proteins (Fuentealba; http://www.hhmi.ucla.edu/derobertis/index.html). DNA affinity purification was done according to [18] starting with the extract from 15 embryos (stg. 12). The DNA probe was produced by annealing the following primers: forward, BioTEG-CGTTCA-GGTCAAAGGTCACGTTCAGGTCAAAGGTCACGTTCAG-GTCAAAGGTCA and reverse, TGACCTTTGACCTGAAC-GTGACCTTTGACCTGAACGTGACCTTTGACCTGAACG. GW501516 or DMSO was added together with 10 ml of equilibrated beads, and the extracts were left rotating for 30 min at room temperature before proteins were pulled down and processed for immunoblotting.
ChIP was done according to [19] but using Dynabeads protein G (Invitrogen). For ChIP-reChIP, we proceeded as for ChIP with 150 embryos as starting material. After the TE buffer wash at the end of the first IP, we eluted DNA/protein complexes in 75 ml of TE/10 mM DTT buffer for 30 min at 37uC. The supernatant was diluted 206with IP buffer. We then proceeded with the second IP, as for a simple ChIP.
Input and immunoprecipitated DNA recovered after de-crosslinking were purified using NucleoSpin Extract II (MachereyNagel) and quantified by qPCR.
The percentage of input was calculated as follows:
E stands for gene-specific efficiency and was calculated as explained in the qPCR section below. Enrichment over a negative control was calculated for each primer pair as the ratio of the percentage of input of the IP over the percentage of input of the negative control. For ChIP with H3K4me3 and H3K27me3 antibodies, we used empty beads as negative control. For ChIP with PPARb antibody, we considered the signal obtained from embryos injected with PPARb MO as the negative control. Sequences of the primers used are available upon request.
RT-qPCR
cDNAs were obtained from 500-1000 ng of Trizol-extracted (Invitrogen) RNA using the Quantitect kit (QIAGEN) or SuperScript II (Invitrogen). qPCR runs were processed on an ABI 7900 (Applied Biosystems) or on a Mx3005P (Stratagene) instrument. For each primer pair, a mean PCR efficiency was established a posteriori considering all of the amplification curves of that pair, regardless of the condition (Co, MO) with the LinRegPCR program [20] . Relative quantities were calculated by qBase [21] using the single gene efficiency option. Sequences of the primers used are available upon request.
Screening for H3K27me3 on the promoters of PPARb promoted genes and control genes PPARb-promoted genes were chosen among the top 200 most downregulated genes upon MO injection in the list presented in Table S1 . The criteria of choice were purely technical: the ability to obtain good primers amplifying a region in the vicinity of the translational start. Similarly, Control genes were taken among genes that did not show a change of expression upon MO injection, according to the RNA-seq. ChIP were done as explained before, but due to the low amount of material in each sample, qPCR were done in duplicate. We considered the tested genes as positive for H3K27me3 when the two following criteria were met: percentage of input .1% and enrichment over mock .5.
Results and Discussion
PPARb is essential for gastrulation movements and antero-posterior axis differentiation in Xenopus laevis
In the adult, PPARb controls many cellular processes that also operate during development [14, 24] , which prompted us to investigate its role using a dedicated model. In our eyes Xenopus laevis presented many advantages for that study. Besides the ease of embryo manipulation and observation it is noteworthy that PPARb has been originally identified in that species [25] . An important point is also that PPARb is highly expressed in the early embryo whereas PPARa is weak and PPARc absent [25] . This led us to speculate that a major role of PPARb would not be masked by partially redundant actions of the two other isotypes.
We detected endogenous PPARb protein in all cell nuclei throughout embryogenesis, with a strong increase during gastrulation to levels that then persisted in subsequent developmental stages ( Fig. S1C-L ). This pattern of receptor protein expression correlates with mRNA expression [25] and suggests a prominent function for PPARb during gastrulation.
This putative role was addressed with a loss-of-function analysis using an antisense morpholino (MO) (Fig. 1A ) [26] . PPARb MOinjected embryos showed a marked decrease in PPARb protein levels ( Fig. 1B) , which correlated with a severe reduction in the length of the anterior-posterior axis ( Fig. 1C-D) . These embryos died shortly after their control siblings reached tail-bud stage. This dramatic phenotype can be entirely attributed to the lack of PPARb because control morpholino (Co) injection caused no anomaly and PPARb_Rescue mRNA co-injection together with PPARb MO restored a normal phenotype (Fig. 1C-D) .
We verified that PPARb MO disrupted gastrulation movement by selectively targeting the dorsal marginal zone with a combination of PPARb MO or Co and fluorescent dye ( Fig.  S2 ). At tail-bud stage, PPARb MO-injected embryos had reduced head and neural tissues and no eyes (Fig. S3 ). Moreover, a disorganized mass of cells occupied the place of the muscles, and a cell-adhesion defect was obvious (Fig. S3) . These results were supported at neurula stage by reduced expression of marker genes consistent with defects in brain (Krox20) and muscle (actc1, myod1) differentiation ( Fig. 2A) . Of interest, PPARb already had affected the future neural (engrailed and krox20) and muscle (actc1 and myod1) differentiation before the onset of the gastrulation movements (Fig. 2B ).
Gastrulation is a stage of intense changes in transcript level
We evaluated the relevance of this early gastrula stage control of differentiation marker expression by using data available from a recent transcriptomic report [23] . We determined changes in the level of many transcripts during normal X. laevis development. Based on analysis of a period ranging from cleavage to the feeding tadpole stages, the transition from mid-to late gastrula corresponded to the stage of highest variations in individual transcript levels, whether an increase or decrease (Fig. 3A) . The genes that were strongly activated during gastrulation maintained their higher level of expression throughout subsequent stages (Fig. 3B) , indicating that expression changes at gastrula were not limited to genes solely required for gastrulation itself but also included several potential differentiation regulators.
Transcriptomic analysis of PPARb knock-down
Because of the importance of this stage in the reorganization of the transcription profile, we analysed the impact of PPARb on the transcriptome by RNA-seq (Fig. 4A , Table S1 and Fig. S4 , and Methods). A clear PPAR signature was revealed; most of the X. laevis orthologs of human genes with a predicted peroxisome proliferator-activated receptor response element were stimulated by PPARb at mid-gastrula (Fig. 4B) , suggesting conservation of PPAR function between frogs and mammals. The RNA-seq data also confirmed the histology and marker gene expression presented above, i.e., PPARb promotes developmental functions related to muscle and neural differentiation (Fig. 4C) . Of importance, neuroectoderm and mesoderm specification was not reduced by the lack of PPARb, and the latter was even increased dorsally ( Fig. 2C-E and Fig. 4C ). Thus, we excluded the possibility that down-regulation of differentiation genes was the indirect consequence of a lack of germ layer induction. Collectively, our analyses identified PPARb as a major promoter of differentiation in vivo. In support of this finding, PPARb controlled the expression of the majority of the genes whose RNA level varies the most between the cleavage and gastrula stages, be it a rise or a decline of expression (Fig. 4D) . In fact, this finding indicates a novel, unsuspected role of PPARb in governing a massive wave of transcriptional modifications initiated at early gastrulation and affecting the later differentiation of organs such as muscle or brain. Embryogenesis in PPARb-null mice has not been studied in detail, possibly because defects in placenta formation may complicate the analysis [15] ; however, no gross gastrulation or differentiation defects have been reported to date. This gap suggests that either PPARb functions in early mouse embryogenesis are masked by redundancy with other factors or that PPARb has specialized to control cell differentiation in the placenta during evolution.
Chromatin signature of PPARb target genes at gastrulation
Epigenetic mechanisms, such as those described in ESCs, could facilitate such a coordinated broad change in the transcription profile [5, 9] . Of great interest, for many genes that PPARb activated, the mouse orthologs are strongly activated during ESC differentiation [3] (Fig. 4C) . Moreover, PPARb also stimulated genes, which mouse orthologs are bound by the polycomb repressive complex that is known to deposit H3K27me3 marks in ESCs [3] (Fig. 4C) . This association led us to hypothesize cooperation between PPARb and epigenetic marks. We classified X. laevis genes into two groups based on the epigenetic signatures of mouse and/or zebrafish orthologs in pluripotent cells (Discussion S1) [8, 9] : first, the 'K27' group of genes, marked by H3K27me3 regardless of co-occupancy with H3K4me3, and second, the 'K4 only' group, marked by H3K4me3 but not by H3K27me3. Strikingly, PPARb promoted transcription of a significant fraction of 'K27' genes but of very few 'K4 only' genes (Fig. S5) . This finding suggested an influence of chromatin marks on PPARb responsiveness, which was even more pronounced when we considered only the 100 genes whose RNA level increased the most during X. laevis gastrulation (same set of genes as in Fig. 4D ). PPARb enhanced expression of 81 of these genes, 44 of which were 'K27' and 25 of which were 'K4 only' (Fig. S5B) . Reciprocally, PPARb repressed 71 out of the 100 most-decreased transcripts at gastrula, and most of these repressed genes (50 genes) were of the 'K4 only' class (Fig. S5B) . Of note, X. laevis putative 'K27' genes were strongly activated very early before the end of gastrulation while 'K4 only' genes were mostly maternal with high, relatively steady RNA levels over time (Fig. S6) . Because of the possible presence of maternally inherited transcripts for the 'K4 only' genes, it was not possible to separate these sets of genes in inactive and active genes at gastrulation. All together, the data indicated that, Xenopus orthologs of ESCs genes marked by H3K27me3 are synchronously induced at gastrula and globally promoted by PPARb. On the contrary, Xenopus orthologs of genes marked by H3K4me3 are globally repressed by PPARb with their RNA level being stable or in slight decrease over gastrulation. In ESCs, genes marked by H3K27me3 during pluripotent stage are globally induced during ESC differentiation, while H3K4me3 genes become repressed [1] . Therefore our data show that X. laevis gastrulation is transcriptionally closely related to ESC differentiation, which was not anticipated. Is there a mechanism of synchronous activation that is conserved in Xenopus and mouse? Could it be that an epigenetic signature of pluripotency is established in the course of X. laevis early development and involves orthologs of genes marked in ESCs?
Based on present knowledge, this would be surprising because (i) epigenetic signatures of pluripotency are poorly conserved across species in general (even between mammals) and (ii) X. laevis is thought to be deprived of them (Discussion S1) [27] .
This prompted us to explore the possibility that H3K27me3 and H3K4me3 are deposited during the pluripotent stages of early X. leavis development and that PPARb cooperates with these epigenetic marks later during gastrulation.
Identification of bivalent genes as a chromatin signature of pluripotency in Xenopus laevis blastula
We reasoned that if epigenetic marks would be conserved between zebrafish and mouse they might also be in X. laevis. Therefore, to challenge the notion of a collaboration of PPARb with epigenetic marks we started by defining a set of X. laevis genes for which the 'K27' or 'K4 only' status of their orthologs is conserved in both fish blastulae and mouse ESCs.
15 X. laevis genes of this set were tested for H3K27me3 and H3K4me3 marks at different developmental stages from blastula (pluripotent stage) to mid-gastrula. From blastula stage onwards, both H3K27me3 and H3K4me3 marks showed a progressive accumulation (Fig. 5A and Fig. S7 ), which is consistent with previous reports [27, 28] . However, in contrast to what has been proposed [27, 28] , we saw no delay in H3K27me3 accumulation as compared to H3K4me3. Of greatest importance, at stage 9 (late blastula), our data fit very well with the predictions derived from ESC and zebrafish blastulae (Fig. 5A) . Indeed, seven of the seven genes predicted to be 'K27' displayed a clear H3K27me3 signal at this stage. These genes were also all enriched in H3K4me3, consistent with the bivalent status of their orthologs in fish and ESCs. Similarly, seven out of the eight predicted 'K4 only' genes were indeed 'K4 only'.
These results suggested the occurrence of bivalent genes in frogs, in contrast to previous findings [27] . We therefore tested the seven validated 'K27/K4' genes by sequential ChIP at the end of the blastula stage (stg. 9) and found that they were all bivalent The group of genes with RNA levels that increased 46or more between stage 11 and stage 13 was considered, and the RNA levels of these genes were plotted at different developmental stages. The rectangles delineate the 25 th and 75 th percentiles, the horizontal bar is the median, and the whiskers indicate the 10 th and 90 th percentiles. doi:10.1371/journal.pone.0083300.g003 (Fig. 5C ). Thus, we show for the first time that X. laevis late blastula cells resemble pluripotent ESCs and fish blastula cells with respect to H3K4me3 and H3K27me3 marks. We conclude that this epigenetic signature of pluripotency is present in frogs, and might thus be a common feature of vertebrates.
H3K27me3 marks serve as cues for activation by PPARb at gastrula
What is most important from this work is the finding that validated 'K27' genes encoded transcripts that showed an abrupt increase at gastrula stage (Fig. S6C) were promoted by PPARb at this stage (Fig. 5A) . Moreover, five of these genes are most likely direct PPARb target genes because PPARb occupied their chromatin at this stage (Fig. 5D) . Thus, PPARb and polycomb complex activity converge to promote transcription of early developmental regulators at gastrulation. This conclusion raised the question of any functional interdependence between these two pathways. Analysis of H3K4me3 and H3K27me3 marks in PPARb-depleted embryos revealed no major changes compared to the control at stage 10.5 (Fig. 5A) . PPARb therefore does not affect H3K27me3 or H3K4me3 deposition, excluding the possibility that the decreased RNA levels observed for 'K27' genes upon PPARb MO injection resulted from differences in the level of activating or repressing epigenetic marks. Rather, PPARb appears to read the epigenetic status of target genes and preferentially activate the 'K27' genes.
However, this conclusion is based on only 6 X. laevis genes that are part of a subset of 'ultra-conserved' genes with respect to Fig. 7 ). Variation in RNA expression upon PPARb MO injection was obtained from the RNA-seq data or from qPCR validations. (B) ChIP with H3K27me3 antibody was conducted at stage 9 on 37 'PPARb promoted genes' and on 27 Control genes. PPARb promoted genes were chosen among the top 200 most downregulated genes at stage 11, upon MO injection in the list presented in Table S1 , while Control genes did not show a change of expression upon MO injection. Results are pluripotency signature. We thus wanted to test additional genes with no a priori on their epigenetic state. We reasoned that if PPARb preferentially activated K27 genes, then there should be more K27 genes among genes that are promoted by PPARb at gastrula than among genes that are not affected by PPARb MO. To test this idea, we screened for the K27 mark at late blastula (see Material and Methods) on a set of genes that are later strongly activated by PPARb and on a set of control genes. 14 out of the 35 PPARb target genes were scored positive for K27, whereas only one out of the 27 control genes was K27 positive (Fig.5B ; Fisher exact test, P,0.005). The low level of K27 in control genes (less than 4%) is consistent with the low level of H3K27me3 marks observed by mass spectrometry at this stage [29] . Finally, when results presented in Fig. 5A and B are taken together, we have identified 22 K27 genes on a total of 78 genes investigated, and 20 of them are promoted by PPARb. This is a clear support of our hypothesis that PPARb collaborates with K27 mark to promote gene expression.
To get more insights into this collaboration, we combined MO injection with treatment of developing embryos with DZNep, a drug that inhibits the activity of polycomb repressive complex 2 in mammals [30] . This treatment was efficient at limiting H3K27me3 deposition in frog embryos (Fig. 5E) . At the highest dose of DZNep, PPARb no longer promoted transcription of its direct 'K27' targets genes (hoxa7, hoxa9, sox8, hoxa3, and cdx4) (Fig. 5E) . However, for evx1, which is not a PPARb direct target gene (Fig. 5D) , the indirect PPARb effect remained in spite of a 136 reduction in H3K27me3 level at this locus (Fig. 5E) . Finally, for hoxa7, hoxa2 and cdx4, PPARb binding was abrogated in the presence of the highest dose of DZNep (Fig. 5E ), which suggests that at least for these genes, the H3K27me3 mark contributes to the recruitment or stabilization of PPARb on their promoter region at gastrulation.
Collectively, these data provide a proof of concept that in vivo, a transcription factor can recognize chromatin status established at pluripotent stage and modulate its activity accordingly: epigenetic marks deposited at the end of the pluripotent stage (late blastula) can influence later gene expression at gastrula under the control of PPARb. In particular, our data challenge the interpretation that H3K27me3 can counteract only an activating effect of the H3K4me3 mark on bivalent genes [3, 5] ; instead, they show that H3K27me3 can serve as a cue to stimulate gene transcription. At first sight, this finding seems to contradict the well-documented role of H3K27me3 in gene repression; however, it parallels previous observations that in the course of mouse ESC differentiation, some genes are activated even if their promoter is occupied by polycomb proteins and clearly marked by H3K27me3 [10] . It is also consistent with the phenotype of mice and of Xenopus embryos lacking PRC2 function that show delayed or impaired induction of early differentiation genes [28, 31, 32] . The present works shows that X. laevis can be a model of choice to study the relation between epigenetic marks and the switch between pluripotency and differentiation in vivo. X. laevis blastulae and gastrulae cells are somehow comparable to pluripotent and differentiating ESCs, respectively. Furthermore, the identification of PPARb as a crucial factor that interprets the chromatin signature of pluripotency in this system could serve as a hook for further mechanistic investigation. Figure S1 A dedicated peptide-derived antibody detects endogenous PPARb protein throughout Xenopus laevis early development. 
Supporting Information
(XLS)
Protocol S1 Functional analysis of RNA-seq data and Most-induced and most-decreased transcripts at gastrulation definition.
(DOCX) Discussion S1 Choice of epigenetic signatures of pluripotency.
(DOCX)
